Covid-19 Vaccine Developer Soars in Shanghai Market Debut

  • 📰 WSJ
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Shares of a Covid-19 vaccine developer nearly doubled after listing on Shanghai’s high-tech STAR market

Shares in China’s CanSino Biologics Inc., one of several companies racing to develop a Covid-19 vaccine, leapt on their first day of trading on a Nasdaq-style tech board in Shanghai.

A global scramble is under way to bring Covid-19 vaccines to market. CanSino is working closely with China’s military and is one of the country’s leading contenders, alongside state-owned China National Pharmaceutical Group Co., or Sinopharm, and a smaller private firm, Sinovac Biotech Ltd.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Is it true that Trump wants to renege on contracts with AstraZeneca, Pfizer/BioNTech & Moderna to buy millions of their Covid-19 vaccines because they deliberately allowed Russian & Chinese companies to deny him a victory lap?

Whistleblower Dr LiMeng Yan: Covid19 is a lab modified virus from a bat ‼️‼️‼️coronavirus discovered by CCP military ‼️‼️‼️

Hahahaha so firstly China give the virus to the world and miraculously want to sell a vaccine hahahaha fkn hilarious

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines